InspireMD Inc expected to post a loss of 30 cents a share - Earnings Preview

InspireMD

04/08/2023 19:40

* InspireMD Inc  NSPR.OQ   NSPR.O  is expected to show a
rise in
quarterly revenue when it reports  results on August 8. 
    * The Tel Aviv-yafo Israel-based   company is expected to
report 
a 1.0% increase in revenue to $1.546 million from $1.53 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for InspireMD Inc is
for a
loss of 30 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for InspireMD
Inc is
$4.13​, above​ its last closing price of $2.98. ​​​

This summary was machine generated August 4 at 18:39 GMT.  All
figures in US dollars  unless otherwise stated